Abstract:Alzheimer's disease is the most common neurodegenerative disease in the elderly. The pathogenesis of the disease is still unkown. β-amyloid (Aβ) has been demonstrated to involve the molecular mechanism of the disease. The aim of the present study is to investigate the toxic effect of the carboxyl-terminal peptide of β-amyloid precursor protein (APPC31) on Neuro2a cells as well as its role in the toxic process in Neuro2a cells induced by Aβ 42 in vitro. The plasmid vector and the APPC31 construct were transiently transfected into Neuro2a cells respectively by lipofectamine 2000. The viability of the cells was measured by the methyl thiazolyl tetrazolium (MTT) assay at 48 h after transfection, and their morphocytology was observed by 4,6-diamino-2-phenyl indole (DAPI) nucleus staining. Afterword different constructs including vector, WTAPP695, APP(D664A), the amino-terminal peptide of β-amyloid precursor protein (APPΔC31) and APPC31 were transiently transfected into Neuro2a cells respectively via the same method. At 24 h after transfection Aβ42 was added into the culture medium of Neuro2a cells with the desired concentration for another 24 h for cell studies. The viability and morphocytology of the cells were measured by using the MTT assay and DAPI nucleus staining, respectively. When incubated in the absence of Aβ42, the viability of cells transfected with vector and APPC31 construct were respective 0.81 ± 0.10 and 0.88 ± 0.12, and accordingly there was no significant difference between the these two groups (t = -0.78, P = 0.48); meanwhile no obvious cell nuclear morphological changes of apoptosis or death occurred. However when incubated in the presence of Aβ42, the viability of cells transfected with vector, WTAPP695, APP(D664A), APP–3C31 and APPC31 constructs were respective 0.82 ± 0.01, 0.78 ± 0.03, 0.55 ± 0.04, 0.81 ± 0.04, 0.78 ± 0.02 and 0.54 ± 0.02. The viability of cells transfected with WTAPP construct and APPC31 construct decreased significantly (F = 47.53, P<0.05) compared with the control group, meanwhile cells displayed condensed nuclear and even nuclear fragmentation. The overexpression of a certain level of APPC31 in Neuro2a cells failed to cause cell death, but this short peptide enhanced cytotoxicity induced by Aβ42 in Neuro2a cells. Thus, these results provided the experimental basis for the further explication of the pathogenesis of Alzheimer's disease.

Construction of coexpression cell model of human amyloid protein recursor 695 gene and human nicotinic acetylcholinergicα4β2 subunit genes

Construction of SH-EP1-α4β2-hAPP695 Cell Line and Effects of Nicotinic Agonists on Β-Amyloid in the Cells

Activation of Α7 Nicotinic Receptor Affects APP Processing by Regulating Secretase Activity in SH-EP1-α7 Nachr-Happ695 Cells

Generation of Stable Cell Lines of APP695 (K595N, M596L) Gene Over-Expression via Lentiviral Over-Expression System

Establishment of A Cellular Model for Alzheimer'S Disease by Overexpressing Swedish-Type Mutated App695

An over Expression App Model for Anti-Alzheimer Disease Drug Screening Created by Zinc Finger Nuclease Technology

Establishment of a Stable AT1R-expressed and Aβ Secretion HEK293 Cell Line

Construction of human Alzheimer's disease' APP-expressing Plasmid

The Construction of a Screening System of Human Amyloid Precursor Protein and Enhanced Fluorescence Protein Fusion Gene

Nicotine Decreases Beta-Amyloid Through Regulating BACE1 Transcription in SH-EP1-α4β2 nAChR-APP695 Cells

Cleavage of Mutant Amyloid Precursor Protein Labeled by Fluorescent Protein in Cells

Construction of Human Islet Amyloid Polypeptide Expression Vector

Construction of Drug Screening Cell Model and Application to New Compounds Interfering Production and Accumulation of Beta-Amyloid by Inhibiting Gamma-Secretase

APP Cleavage in Live Cells Guided by C99

Nicotine Decreases Beta-Amyloid Through Regulating Bace1 Transcription In Sh-Ep1-Alpha 4 Beta 2 Nachr-App695 Cells

Construction and Function of Stable Mammalian Cell Lines Expressing the Aβ-specific Single Chain Fragment Variants

Amyloid Precursor Protein Fragment and Acetylcholinesterase Increase with Cell Confluence and Differentiation in A Neuronal Cell Line

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

Construction of recombinant plasmid pIRES2-EGFP-Aβ_(42) and expression of Aβ_(42) in N2a cells

Amyloid Precursor Protein Revisited: NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES

Amyolid Precursor Protein Mediates Presynaptic Localization and Activity of the High-Affinity Choline Transporter